Evidence map›Paper›PMID 39314972›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Psychiatric, Neurological, and Somatic Comorbidities in Intermittent Explosive Disorder: a retrospective cohort study of electronic health records.

Yanli Zhang-James, John Paliakkara, Joshua Schaeffer, Joseph Strayhorn, Stephen V Faraone

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Yanli Zhang-JamesNorton College of Medicine at SUNY Upstate Medical University, Department of Psychiatry and Behavioral Sciences, 505 Irving Ave, Syracuse, NY 13210 USA.ORCID 0000-0002-2104-0963
John PaliakkaraNorton College of Medicine at SUNY Upstate Medical University, Department of Family Medicine, 766 Irving Ave, Syracuse, NY 13210, Syracuse, NY 13210 USA.
Joshua SchaefferRoss University School of Medicine, 10315 USA Today Way, Miramar, FL 33025.
Joseph StrayhornNorton College of Medicine at Upstate Medical University, Clinical Psychology Psychiatry and Behavioral Sciences, 719 Harrison Street, Syracuse, NY 13210 USA.
Stephen V FaraoneNorton College of Medicine at SUNY Upstate Medical University, Department of Psychiatry and Behavioral Sciences, 505 Irving Ave, Syracuse, NY 13210 USA.ORCID 0000-0002-9217-3982

Funding

SLE Treatment with N-acetylcysteineU01AR076092 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI Michael P McDermott, Andras Perl · 2020 to 2026
$7.9M
Person-centered diagnostics and prediction for child dysregulatory psychopathology using novel phenotypesU01MH135970 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARALUNAS, SARAH LYN, NAGEL, BONNIE J. · 2024 to 2025
$6.5M
Discoveries in ADHD genomics: Help or hype in clinical settings?R01MH116037 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DOYLE, ALYSA E · 2019 to 2023
$4.4M
Polygenic and environmental contributions to ADHD trajectory and outcome from childhood through adolescenceR01MH131685 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI Michael A Mooney, Molly Nikolas · 2023 to 2026
$3.1M
Leveraging computational strategies to disentangle the genetic and neural underpinnings of ADHD and its associated cognitive systemsR01MH130899 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI Tian Ge · 2023 to 2026
$3.0M
Integrating Genetic, Neuroimaging, Transcriptomic, and Clinical Risk Factors as Multivariate Predictors of Cognitive Deterioration in Alzheimer's Disease.R01NS128535 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI HESS, JONATHAN · 2022 to 2024
$1.2M
NIAMS NIH HHS U01 AR076092NIMH NIH HHS R01 MH116037NIMH NIH HHS R01 MH130899NIMH NIH HHS R01 MH131685NIMH NIH HHS U01 MH135970NINDS NIH HHS R01 NS128535
6 · The paper itself

Abstract

Importance: Intermittent Explosive Disorder (IED) is an understudied psychiatric condition that presents with repeated episodes of impulsive aggression and poorly regulated emotional control, often resulting in interpersonal and societal consequences. Better understanding of comorbidities will allow for enhanced screening, diagnosis, and treatment of patients. Objective: To investigate prevalence and associations of IED with psychiatric, neurological, and somatic disorders using real-world data. Design: Matched cohorts of patients with or without IED diagnosis were identified using data from the TriNetX Research Network (until January 31, 2024). Cox proportional hazard models were used to estimate and compare the probabilities of acquiring other diagnoses using patients' available medical records. Setting: Analysis of electronic medical records from two patient populations. Participants: 30,357 individuals with IED and equal number of demographically matched individuals without IED from the TriNetX Research. Exposure: IED diagnosis identified through the associated ICD codes. Main Outcomes and Measures: The main outcomes were ICD-10-CM diagnostic categories and root codes for disorders and health conditions in both cohorts. Main measures are total numbers and proportions of patients who had the diagnostic codes, as well as adjusted hazard ratios for IED diagnosis. Results: Although only 0.03% of the total patient population had an IED diagnosis, we found extensive and widespread comorbidities with psychiatric, neurological and somatic conditions. A significant 95.7% of the individuals with IED had another psychiatric diagnosis. All psychiatric sub-categories and 95% of the psychiatric diagnoses were significantly associated with IED, with HRs ranging from 2 to 77. Among neurological conditions, neurodegenerative diseases and epilepsy had the highest HRs, followed by extrapyramidal and movement disorders, cerebral palsy and other paralytic syndromes, and sleep disorders. Notable associations with IED also includes conditions such as obesity, hyperlipidemia, hypertension, and GERD. Conclusion and Relevance: Our findings illuminate the extensive comorbid relationships between IED and psychiatric, neurological, and somatic disorders. This underscores the necessity for an integrated diagnostic and treatment approach that addresses both the psychological and physical health aspects of IED. Additionally, our work highlights the need for more accurate and inclusive diagnosis of IED in patients with mental disorders.

Indexed as

comorbidityelectronic health recordhazard ratioIntermittent Explosive Disorderneurologicalprevalencepsychiatric

Identifiers

PMID39314972
PMCPMC11419232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.